Therapeutic complement inhibition: a promising approach for treatment of neuroimmunological diseases.

about

Therapeutic complement inhibition: a promising approach for treatment of neuroimmunological diseases.

Item

http://www.wikidata.org/entity/Q39090725

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Therapeutic complement inhibit ...... f neuroimmunological diseases.

@en

Therapeutic complement inhibit ...... f neuroimmunological diseases.

@nl

type

Item

label

Therapeutic complement inhibit ...... f neuroimmunological diseases.

@en

Therapeutic complement inhibit ...... f neuroimmunological diseases.

@nl

prefLabel

Therapeutic complement inhibit ...... f neuroimmunological diseases.

@en

Therapeutic complement inhibit ...... f neuroimmunological diseases.

@nl

P1476

Therapeutic complement inhibit ...... f neuroimmunological diseases.

@en

P2093

Benjamin R Wakerley

http://www.w3.org/2001/XMLSchema#string

Nobuhiro Yuki

http://www.w3.org/2001/XMLSchema#string

Peter J Spaeth

http://www.w3.org/2001/XMLSchema#string

P2860

Characterization of early and terminal complement proteins associated with polymorphonuclear leukocytes in vitro and in vivo after spinal cord injury

Guillain–Barré Syndrome

An Unusual Variant of Acute Idiopathic Polyneuritis (Syndrome of Ophthalmoplegia, Ataxia and Areflexia)

Guillain–Barré and Miller Fisher syndromes—new diagnostic classification

Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study

Aquaporin 4 and neuromyelitis optica

Cellular and molecular mediators of neuroinflammation in the pathogenesis of Parkinson's disease

A common fold mediates vertebrate defense and bacterial attack

A Prospective, Multicenter, Randomized Phase II Study to Evaluate the Efficacy and Safety of Eculizumab in Patients with Guillain-Barré Syndrome (GBS): Protocol of Japanese Eculizumab Trial for GBS (JET-GBS)

Treatment of neuromyelitis optica: state-of-the-art and emerging therapies

P304

579-591

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14737175.2017.1282821

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kjara S Pilch

P577

2017-01-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28092989

http://www.w3.org/2001/XMLSchema#string